QUAZAR AML-001 Archives - Medical Conferences

Oral azacitidine improves overall survival in patients with acute myeloid leukaemia

Presented By

Prof. Hartmut Döhner, Universitätsklinikum Ulm, Germany

Trial

Phase 2, QUAZAR AML-001

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:59

Presented By

Dr Andrew Wei, Alfred Hospital, Australia

Trial

Phase 3, QUAZAR AML-001

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 21:39

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com